Solution brought to hospitals quickly and in full compliance with safety regulations Leuven (Belgium) – April 6, 2020. In the fight against the coronavirus crisis, hospitals are in dire need of mechanical ventilators to treat COVID 19 patients. In response to this shortage, Materialise, a Belgium-based Read More
Investment will allow Materialise to bring benefits of personalized 3D printed implants to Brazil Leuven, Belgium / Rio Claro, Brazil – August 1, 2019. Materialise, a global leader in 3D printing solutions, today announced a strategic investment in Engimplan, a Brazil-based manufacturer of orthopedic and Read More
Partnership with Formlabs creates complete, cost-effective solution for 3D print labs PLYMOUTH, MICH., Nov. 28, 2017 – Materialise, a leading provider of 3D printing services and software solutions, and Formlabs, a respective leader in the 3D printing industry, are collaborating to deliver a complete, cost-effective Read More
Partnership with Siemens Healthineers expands availability of Materialise Mimics inPrint software PLYMOUTH, MICH., Nov. 27, 2017. Materialise NV (Nasdaq: MTLS), a leading provider of 3D printing services and software solutions, and Siemens Healthineers, a leading medical technology company announced today that they are joining forces Read More
Non-invasive mitral valve market requires high-quality, 3D planning PLYMOUTH, MICH., Oct. 26, 2017 – Mitral regurgitation affects more than 4 million Americans – nearly one in 10 people aged 75 or older. Currently the primary option for the disease is open-heart surgery, which holds extremely Read More
Materialise’s patient-specific implants will be distributed by DePuy Synthes under the TRUMATCH® CMF brand name Leuven, Belgium – September 11, 2017. Materialise NV (Nasdaq: MTLS) announced today that U.S. patients can now benefit from their patient-specific implants, 3D-printed in titanium for maxillofacial surgery. As the Read More
Enhanced patient screening and patient planning improve efficiency and outcomes of clinical trials PLYMOUTH, MICH., June 14, 2017 –Cardiovascular medical device developers and clinicians are often required to conduct clinical trials for their devices and proceduresto ensure they will perform safely and effectively across their Read More